SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-20-077565
Filing Date
2020-06-29
Accepted
2020-06-26 18:18:48
Documents
15
Period of Report
2020-06-26
Items
Item 5.01: Changes in Control of Registrant
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2023545-1_8k.htm   iXBRL 8-K 54208
2 EXHIBIT 3.1 tm2023545d1_ex3-1.htm EX-3.1 42225
3 EXHIBIT 3.2 tm2023545d1_ex3-2.htm EX-3.2 126244
4 EXHIBIT 10.1 tm2023545d1_ex10-1.htm EX-10.1 134283
  Complete submission text file 0001104659-20-077565.txt   612746

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA uthr-20200626.xsd EX-101.SCH 3183
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE uthr-20200626_lab.xml EX-101.LAB 34591
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE uthr-20200626_pre.xml EX-101.PRE 22708
10 EXTRACTED XBRL INSTANCE DOCUMENT tm2023545-1_8k_htm.xml XML 3617
Mailing Address 1040 SPRING ST SILVER SPRING MD 20910
Business Address 1040 SPRING ST SILVER SPRING MD 20910 3016089292
UNITED THERAPEUTICS Corp (Filer) CIK: 0001082554 (see all company filings)

IRS No.: 521984749 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-26301 | Film No.: 20995444
SIC: 2834 Pharmaceutical Preparations